For the Inventor, By the Inventor

Enter assignee name

's-Hertogenbosch, Netherlands

Pamgene Bv

USPTO Granted Patents = 16

EPO Patents = 17

Trademarks = 1

Forward Citations = 79

Loading Chart...

Loading Chart...

51 inventors (with patents filed for the assignee):

Robby Ruijtenbeek (8 out of 8 patents)

Richard De Wijn (4 out of 4 patents)

Maria Helena Hilhorst (3 out of 4 patents)

4. Marinus Gerardus Johannes Van Beuningen (2 out of 2 patents)

5. Pieter Jacob Boender (2 out of 4 patents)

6. Hendrik Sibolt Van Damme (2 out of 5 patents)

7. Wilhemus M Carpay (2 out of 2 patents)

8. Roeland F Papen (2 out of 13 patents)

9. Liesbeth Coosje Hovestad-Bijl (1 out of 1 patent)

10. Hermanus Johannes Maria Kreuwel (1 out of 10 patents)

11. Jeroen Van Ameijde (1 out of 1 patent)

12. Robertus Matthias Joseph Liskamp (1 out of 2 patents)

13. René Houtman (1 out of 1 patent)

14. Arzu Umar (1 out of 1 patent)

15. Johannes Albert Foekens (1 out of 1 patent)

16 patents: Sort by Forward Citations

1. 11802315 - Method for predicting the response of non-small-cell lung carcinoma patients to a medicament (2023-10-31),

2. 10604786 - Method for predicting the response of melanoma patients to targeted pharmacotherapy (2020-03-31),

3. 9448237 - Modified tyrosine amino acids, peptides containing them, and their use for detecting hydrolase enzyme activity (2016-09-20),

4. 9128087 - Nuclear receptor assay (2015-09-08),

5. 9075061 - Method for determining the estrogen receptor status of breast cancer (2015-07-07),

6. 8962268 - Method for determining survival prognosis of patients suffering from non-small cell lung cancer (NSCLC) (2015-02-24),

7. 8962267 - Method for predicting the response of non-small cell lung cancer patients to targeted pharmacotherapy (2015-02-24),

8. 8617836 - Method for predicting the response of locally advanced rectal cancer to chemoradiotherapy (2013-12-31),

9. 7504209 - Method and device for integrated nucleic acid integrity assessment and analysis (2009-03-17),

10. 7473562 - Method for high-throughput integrated chemical and biochemical reactions (2009-01-06),

11. 7364848 - Integrated microarray analysis (2008-04-29),

12. 7105134 - Device for holding a substrate (2006-09-12),

13. 6849408 - Analytical test device with substrate having oriented through going channels and improved methods and apparatus for using same (2005-02-01),

14. 6635493 - Device for performing an assay, a method for manufacturing said device, and use of a membrane in the manufacture of said device (2003-10-21),

15. 6383748 - Analytical test device with substrate having oriented through going channels and improved methods and apparatus for using same (2002-05-07),

PAMGENE BV is a leading provider of innovative genomic solutions and services for the pharmaceutical and biotech industries. With a focus on personalized medicine, PAMGENE offers a wide range of advanced genotyping, gene expression, and pathway analysis solutions. Their state-of-the-art technologies enable researchers to make informed decisions during drug development, leading to improved clinical outcomes. PAMGENE's commitment to excellence and customer satisfaction has earned them a strong reputation in the industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

16 Patents

#3 in 's-Hertogenbosch

#427 in Netherlands

#36,617 in the World

's-Hertogenbosch, Netherlands

Pamgene Bv

Forward Citations = 79

51 inventors:

Robby Ruijtenbeek (8 out of 8 patents)

Richard De Wijn (4 out of 4 patents)

Maria Helena Hilhorst (3 out of 4 patents)

4. Marinus Gerardus Johannes Van Beuningen (2 out of 2 patents)

5. Pieter Jacob Boender (2 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…